Proteolysis-targeting chimera molecules targeting SHP2
D Yu, M Zheng, Y Liu, L Chen, H Li - Future Medicinal Chemistry, 2022 - Future Science
SHP2 is a member of the non-receptor protein tyrosine phosphatases, encoded by PTPN11,
and exhibits oncogenic activities. The close association between SHP2 and human cancer …
and exhibits oncogenic activities. The close association between SHP2 and human cancer …
Strategies targeting protein tyrosine phosphatase SHP2 for cancer therapy
Y Song, S Wang, M Zhao, X Yang… - Journal of Medicinal …, 2022 - ACS Publications
The protein tyrosine phosphatase SHP2 encoded by PTPN11 is a promising therapeutic
target for cancer therapy, while the multifaceted roles of SHP2 complicate the drug discovery …
target for cancer therapy, while the multifaceted roles of SHP2 complicate the drug discovery …
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders
X Yang, Z Wang, Y Pei, N Song, L Xu, B Feng… - European Journal of …, 2021 - Elsevier
SHP2, a non-receptor tyrosine phosphatase, plays a pivotal role in numerous oncogenic cell-
signaling cascades like RAS-ERK, PI3K-AKT and JAK-STAT. On the other hand, proteolysis …
signaling cascades like RAS-ERK, PI3K-AKT and JAK-STAT. On the other hand, proteolysis …
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
Phosphorylation is a reversible post-translational modification regulated by phosphorylase
and dephosphorylase to mediate important cellular events. Src homology-2-containing …
and dephosphorylase to mediate important cellular events. Src homology-2-containing …
Targeting SHP2 for Cancer Treatment: Advances and Prospects
Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2), encoded by the
PTPN11, is a non-receptor protein tyrosine phosphatase that expressed in cytoplasmic …
PTPN11, is a non-receptor protein tyrosine phosphatase that expressed in cytoplasmic …
Discovery of SHP2-D26 as a first, potent, and effective PROTAC degrader of SHP2 protein
M Wang, J Lu, M Wang, CY Yang… - Journal of medicinal …, 2020 - ACS Publications
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive therapeutic target
for human cancers and other human diseases. Herein, we report our discovery of potent …
for human cancers and other human diseases. Herein, we report our discovery of potent …
Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery
Y Song, X Yang, S Wang, M Zhao… - Medicinal Research …, 2022 - Wiley Online Library
The protein tyrosine phosphatase SHP2 encoded by PTPN11 is a promising therapeutic
target for cancer therapy. The dynamic change of SHP2 between closed and open …
target for cancer therapy. The dynamic change of SHP2 between closed and open …
Therapeutic potential of targeting SHP2 in human developmental disorders and cancers
D Shen, W Chen, J Zhu, G Wu, R Shen, M Xi… - European Journal of …, 2020 - Elsevier
Abstract Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), encoded
by PTPN11, regulates cell proliferation, differentiation, apoptosis and survival via releasing …
by PTPN11, regulates cell proliferation, differentiation, apoptosis and survival via releasing …
[HTML][HTML] Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive target for cancer
therapy due to its multifaceted roles in both tumor and immune cells. Herein, we designed …
therapy due to its multifaceted roles in both tumor and immune cells. Herein, we designed …
Novel PROTACs for degradation of SHP2 protein
M Zheng, Y Liu, C Wu, K Yang, Q Wang, Y Zhou… - Bioorganic …, 2021 - Elsevier
Protein tyrosine phosphatase SHP2 is a member of PTPs family associated with cancer such
as leukemia, non-small cell lung cancer, breast cancer, and so on. SHP2 is a promising …
as leukemia, non-small cell lung cancer, breast cancer, and so on. SHP2 is a promising …